Click Therapeutics

United States · Healthtech

Click Therapeutics develops physician-prescribed software treatments delivered through smartphones.

Product

Click Therapeutics develops and commercializes prescription digital treatments for patients and clinicians. Its platform combines software, neuroscience and machine learning to deliver structured interventions through a phone.

The company works with pharmaceutical partners on standalone digital treatments and software used alongside medicines. Its product portfolio spans depression, schizophrenia, episodic migraine and type 2 diabetes.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series D$50MBoehringer Ingelheim — Participant
Sourcesclicktherapeutics.com ↗clicktherapeutics.com ↗